
USFDA APPLICATION NUMBER - 202091 / DOSAGE - FOR SUSPENSION;ORAL - 500MG/5ML
| Active Ingredient/Active Moiety | ||
| Ingredient Name | Basis of Strength | Strength |
|---|---|---|
| CEFIXIME(UNII: 97I1C92E55) (CEFIXIME ANHYDROUS - UNII:XZ7BG04GJX) | CEFIXIME ANHYDROUS | 500mg in 5 | 100mg | 200mg in 5 | 200mg | 400mg | 400mg |
Inactive Ingredients
| Ingredient Name | LUPIN LIMITED |
|---|---|
| ALUMINUM OXIDE(LMI26O6933) | |
| ASPARTAME(Z0H242BBR1) | |
| CELLULOSE, MICROCRYSTALLINE(OP1R32D61U) | |
| CROSPOVIDONE(68401960MK) | |
| DIBASIC CALCIUM PHOSPHATE DIHYDRATE(O7TSZ97GEP) | |
| FD&C RED NO. 40(WZB9127XOA) | |
| FERRIC OXIDE RED(1K09F3G675) | |
| FERROSOFERRIC OXIDE(XM0M87F357) | |
| GELATIN(2G86QN327L) | |
| HYDROXYPROPYL CELLULOSE, LOW SUBSTITUTED(2165RE0K14) | |
| HYPROMELLOSES(3NXW29V3WO) | |
| LACTOSE MONOHYDRATE(EWQ57Q8I5X) | |
| MAGNESIUM STEARATE(70097M6I30) | |
| MANNITOL(3OWL53L36A) | |
| POLYETHYLENE GLYCOLS(3WJQ0SDW1A) | |
| POTASSIUM HYDROXIDE(WZH3C48M4T) | |
| PROPYLENE GLYCOL(6DC9Q167V3) | |
| SHELLAC(46N107B71O) | |
| SILICON DIOXIDE(ETJ7Z6XBU4) | |
| SODIUM BENZOATE(OJ245FE5EU) | |
| SODIUM LAURYL SULFATE(368GB5141J) | |
| STARCH, PREGELATINIZED CORN(O8232NY3SJ) | |
| STRAWBERRY(4J2TY8Y81V) | |
| SUCRALOSE(96K6UQ3ZD4) | |
| SUCROSE(C151H8M554) | |
| TITANIUM DIOXIDE(15FIX9V2JP) | |
| TRIACETIN(XHX3C3X673) | |
| XANTHAN GUM(TTV12P4NEE) |